Copyright claim: All content of the website are property of Private Pharma company. Any unauthorized re-
Design & Hosting By: PIT Designs.
JOSWE Medical is a private limited liability pharmaceutical manufacturing company established in Jordan since 2000.
Since its establishment JOSWE Medical has positioned itself as one of the leading companies in the region to apply advanced research and development to the generic pharmaceuticals through its strategy of improving the drug delivery technology and thus improving the effectiveness of medicines.
JOSWE Medical has obtained credible feedback from professional medical practitioners and has established a reputation for high quality medicines in the Jordanian and the regional markets.
BORISOVSKIY ZAVOD MEDICINSKIKH PREPARATOV
Status of the leading enterprise of the pharmaceutical branch in the Republic of Belarus with a 50-
The volume of industrial production in current prices in 2015 amounted to -
Pharmaceutical factory “BORISOVSKIY ZAVOD MEDICINSKIKH PREPARATOV”, JSC bets against the continuous development and modernization: more than 300 already mastered manufacturing techniques are supplemented with new technologies; equipment stock is updated regularly and production certification for the compliance with GMP is consistently carried out.
Contemporary equipment, new technologies, the most accurate methods for products quality control, qualified staff -
Amman Pharmaceutical Industries (API) is a rapidly growing specialty pharmaceutical company established in 1989 as a niche pharmaceutical manufacturer.
Located in king Abdullah II industrial estate -
It has been founded with an approach geared towards pharmaceutical excellence and shareholder's return value.
API's management has and continues to place special attention towards its production facilities. Occupying a site of around 5000 Sq.m, more than 90% of the facility is dedicated to production, packaging, R&D, and other production and manufacturing specific activities.
Manufacturing excellence has been exemplified through the accreditation of API facilities and, hence its products, by the authorized pharmaceutical and health bodies of more than 22 countries in which API products are being sold.
Generis currently holds a portfolio of almost 200 different molecules making it the Company with the largest portfolio in Portugal and one the largest in Europe